Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renee M McGovern

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Cancer Chemotherapy and Pharmacology|July 21, 2006
Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primatesStacie L Stapleton, Joel M Reid, Patrick A Thompson, et al.
Gynecologic Oncology|March 22, 2003
TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer riskBobbie S Gostout, Gregory A Poland, Eric S Calhoun, et al.
American Journal of Obstetrics and Gynecology|September 13, 2011
Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasiaDeirdre R Pachman, Debra L Barton, Amy C Clayton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Comparative bioavailability of sulindac in capsule and tablet formulationsJoel M Reid, Sumithra J Mandrekar, Elsa C Carlson, et al.
Pediatric Blood & Cancer|April 5, 2013
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium studyTrent R Hummel, Lars Wagner, Charlotte Ahern, et al.
Endocrinology|October 5, 2017
Skeletal and Uterotrophic Effects of Endoxifen in Female RatsAnne Gingery, Urszula T Iwaniec, Malayannan Subramaniam, et al.
Journal of Clinical Pharmacology|March 31, 2022
Population Pharmacokinetics of Z-Endoxifen in Patients With Advanced Solid TumorsEmily J Koubek, Andrew T Ralya, Thomas R Larson, et al.
Clinical and Translational Science|August 11, 2021
Prospective evaluation of high-dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney functionJason N Barreto, Joel M Reid, Carrie A Thompson, et al.
Pediatric Blood & Cancer|August 14, 2012
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916)Jodi A Muscal, Patrick A Thompson, Terzah M Horton, et al.
Pediatric Blood & Cancer|March 26, 2014
A phase I trial of MK-2206 in children with refractory malignancies: a Children's Oncology Group studyMaryam Fouladi, John P Perentesis, Christine L Phillips, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|July 21, 2006
Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primatesStacie L Stapleton, Joel M Reid, Patrick A Thompson, et al.
Gynecologic Oncology|March 22, 2003
TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer riskBobbie S Gostout, Gregory A Poland, Eric S Calhoun, et al.
American Journal of Obstetrics and Gynecology|September 13, 2011
Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasiaDeirdre R Pachman, Debra L Barton, Amy C Clayton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Comparative bioavailability of sulindac in capsule and tablet formulationsJoel M Reid, Sumithra J Mandrekar, Elsa C Carlson, et al.
Pediatric Blood & Cancer|April 5, 2013
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium studyTrent R Hummel, Lars Wagner, Charlotte Ahern, et al.
Endocrinology|October 5, 2017
Skeletal and Uterotrophic Effects of Endoxifen in Female RatsAnne Gingery, Urszula T Iwaniec, Malayannan Subramaniam, et al.
Journal of Clinical Pharmacology|March 31, 2022
Population Pharmacokinetics of Z-Endoxifen in Patients With Advanced Solid TumorsEmily J Koubek, Andrew T Ralya, Thomas R Larson, et al.
Clinical and Translational Science|August 11, 2021
Prospective evaluation of high-dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney functionJason N Barreto, Joel M Reid, Carrie A Thompson, et al.
Pediatric Blood & Cancer|August 14, 2012
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916)Jodi A Muscal, Patrick A Thompson, Terzah M Horton, et al.
Pediatric Blood & Cancer|March 26, 2014
A phase I trial of MK-2206 in children with refractory malignancies: a Children's Oncology Group studyMaryam Fouladi, John P Perentesis, Christine L Phillips, et al.
Pageof 4